Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Current Status of Analytical Techniques for Characterization of Protein Stability
Dr. Sanket Patke, Research Investigator at Bristol-Myers Squibb with Dr. Joshua Stillahn and Dr Manning
Volume Reduction and Process Optimization with Cadence Inline Concentrator
A SMART Platform for Scalable Biotherapeutic Development: cDNA to 200L Single-Use Stirred-Tank Bioreactor
Benefits of Mixed-Mode Cation Exchange Chromatography: CMM HyperCel™ Sorbent Used for Monoclonal Antibody and Other Recombinant Protein Purification
View All Featured ArticlesHeadline News
Zura Bio discontinues tibulizumab development in hidradenitis suppurativa after Phase II miss
Livdelzi improves ALP normalisation rates in Phase III PBC study
Allergan Aesthetics reports improved facial satisfaction in GLP-1 users after aesthetic treatments
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Next Frontier in Subvisible Particle Analysis: New Tools and Opportunities
Presented by Danny Chou, President and Founder at Compassion BioSolution, LLC and Mark Bumiller, Technology Manager at Entegris, Inc
21st May 2020
Quantification and Control of Amorphous contents by Raman, Application and Case Studies in Pharmaceutical Processing
Presented by Michelle Raikes, M.S., Scientist IV and Dr. Fredrik Nordstrom, Sr Research Fellow at Boehringer Ingelheim and Dr Julia Griffen, Product Manager Transmission Raman Products, Agilent Technologies Inc.
02nd October 2020
Upstream Viral Risk Mitigation Strategy for High Titer Biologics Manufacturing
Presented by Aaron Mack, Engineer at Biogen and Dave Kolwyck, Director Materials Science at Biogen and David Gemmell Senior Process Engineer at Merck
17th October 2019
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Lifetime study for JSR Amsphere A3 – protein A resin
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Column Packing Protocol for Amsphere A3
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
